Neurology Minute

Generic Competition for Dimethyl Fumarate

Informações:

Synopsis

Dr. Jason Crowell talks with 46brooklyn Research CEO Antonio Ciaccia about how Medicare Part D has hidden the benefits of generic competition for Tecfidera, a disease-modifying therapy for multiple sclerosis. Read the full article at 46brooklyn.com. To hear the full podcast: https://www.neurology.org/podcast